Home-based Cardiac Rehabilitation in Heart Failure
Implementing a Home-based Cardiac Rehabilitation Program Among Rural Patients With Heart Failure
1 other identifier
interventional
332
1 country
2
Brief Summary
This study evaluates a mobile health (mHealth) home-based cardiac rehabilitation program for patients with heart failure. We will stratify randomization between rural and urban populations, with the goal to assess implementation of cardiac rehabilitation across these two geographic areas. . The study will randomize 332 patients with heart failure (ejection fraction ≥35%) who are not eligible for center-based rehabilitation to either a 12-week mHealth cardiac rehabilitation program or an attention control group, with outcomes measured over 6 months using a composite endpoint of mortality, hospitalizations, and quality of life. We will then assess the implementation of the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3 heart-failure
Started Aug 2025
Typical duration for phase_3 heart-failure
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2024
CompletedFirst Posted
Study publicly available on registry
April 5, 2024
CompletedStudy Start
First participant enrolled
August 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
August 21, 2025
August 1, 2025
3.3 years
March 31, 2024
August 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite Hierarchical Endpoint
A composite outcome incorporating all-cause mortality, time to first heart failure hospitalization, total heart failure hospitalizations, and a 5-point difference in disease-specific quality of life score as assessed by the Kansas City Cardiomyopathy Questionnaire (KCCQ). The KCCQ ranges from 0-100, where 0 indicates worst quality of life and 100 indicates best quality of life.
6 months.
Secondary Outcomes (5)
Physical Activity Level
Continuously measured over 6 months.
General Health-Related Quality of Life
Baseline, 3 months, and 6 months
Implementation Outcomes
Assessed at 3 and 6 months.
Depressive Symptoms
Baseline, 3 months, and 6 months
Anxiety Symptoms
Baseline, 3 months, and 6 months
Study Arms (2)
Movn cardiac rehabilitation
EXPERIMENTALCardiac rehabilitation delivered through Movn app through the use of mHealth.
Attention Control
ACTIVE COMPARATORThis group will receive a wearable device for step count tracking and will get periodic check ins to minimize differential attention between groups. They will not receive an exercise plan.
Interventions
Participants will have 12-week home-based exercise program delivered via a commercially available home-based cardiac rehabilitation platform called Movn. The plan includes an accelerometer, blood pressure scale, and mobile application.
Participants will receive a FitBit for monitoring of physical function.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older
- History of hospitalization for acute heart failure with ejection fraction ≥ 35%
- Ability to participate in telemedicine visits
- Access to smartphone or device capable of running the mHealth application
- Willingness to participate in home-based cardiac rehabilitation program
You may not qualify if:
- Heart failure with reduced ejection fraction (ejection fraction \< 35%)
- Inability to participate in physical exercise or cardiac rehabilitation due to medical contraindications
- Inability to provide informed consent
- Lack of access to required technology (smartphone, internet connectivity)
- Life expectancy less than 6 months
- Inability to participate in telemedicine visits or remote monitoring
- Current participation in another cardiac rehabilitation program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Texas Southwestern Medical Center
Dallas, Texas, 75209, United States
Baylor Scott and White Health System
Dallas, Texas, 75246, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 31, 2024
First Posted
April 5, 2024
Study Start
August 15, 2025
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
August 21, 2025
Record last verified: 2025-08